---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-012621"
form_type: "8-K"
ticker: "RCKT"
cik: "0001281895"
company_name: "ROCKET PHARMACEUTICALS, INC."
filed_at: "2025-04-07T23:59:59+00:00"
generated_at: "2026-05-23T19:27:29.657886+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Rocket Pharma appoints Sarbani Chaudhuri as Chief Commercial & Medical Affairs Officer

## Summary
- Annual base salary of $525,000 with a target bonus of 45% of salary.
- Equity grant of ~$2,500,000 (50% options, 50% RSUs) vesting over three years.
- One-third of RSUs/options vest at first anniversary; remainder over two years quarterly.
- Sign-on bonus of $100,000 payable 30 days after start date, contingent on employment.
- Severance of 9 months salary plus COBRA; 12 months salary/bonus/COBRA on qualifying change-in-control termination.

## SEC filing metadata
- accession: 0001140361-25-012621
- form_type: 8-K
- ticker: RCKT
- cik: 0001281895
- company_name: ROCKET PHARMACEUTICALS, INC.
- filed_at: 2025-04-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1281895/000114036125012621/0001140361-25-012621-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1281895/000114036125012621/ef20047021_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-012621
- JSON: https://secwatch.observer/filing/0001140361-25-012621.json
- Plain text: https://secwatch.observer/filing/0001140361-25-012621.txt

## Key facts
- Executive change
  Sarbani Chaudhuri was appointed as Chief Commercial & Medical Affairs Officer at ROCKET PHARMACEUTICALS, INC..
  - Action: appointed
  - Role: Chief Commercial & Medical Affairs Officer
  source text: On April 7, 2025, Sarbani Chaudhuri was appointed by Rocket Pharmaceuticals, Inc. (the “Company”) as the Company’s Chief Commercial & Medical Affairs Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1281895/000114036125012621/0001140361-25-012621-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.